{"id":"W2415409512","doi":"10.1016/j.jtho.2016.05.029","title":"Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls","year":2016,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Astellas Pharma; PharmaMar; AstraZeneca; Novartis Pharmaceuticals Corporation; Pfizer; Eli Lilly and Company","keywords":"Crizotinib; Medicine; Ceritinib; Oncology; Alectinib; ALK inhibitor; Internal medicine; Targeted therapy; Lung cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002498401,0.0001848675,0.001097679,0.0002277912,0.00004071453,0.000009944689,0.00008607163,0.000105745,0.00009850662],"category_scores_gemma":[0.00008692704,0.0001023535,0.00007469898,0.0001526592,0.0002299418,0.0002401408,0.00001328682,0.0002069339,0.000001868686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000204622,"about_ca_system_score_gemma":0.000491214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005585101,"about_ca_topic_score_gemma":0.0001364983,"domain_scores_codex":[0.9983066,0.0003327396,0.0007387958,0.0001791078,0.0002174868,0.0002253251],"domain_scores_gemma":[0.9980362,0.0004337914,0.0008001972,0.0001337648,0.0004080186,0.000188011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.09656645,0.005113719,0.1134068,0.0001067323,0.001666546,0.0009303276,0.01668051,0.00006903925,0.1270391,0.000121864,0.00008961281,0.6382093],"study_design_scores_gemma":[0.05622262,0.05498012,0.8323019,0.002575406,0.001891718,0.002069821,0.006266136,0.00008353543,0.04081367,0.000190545,0.002283904,0.0003206551],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946908,0.002127876,0.0002629891,0.001061699,0.00009822232,0.000627535,0.00001587629,0.00001284277,0.001102163],"genre_scores_gemma":[0.9959497,0.0001527798,0.003526145,0.0001286071,0.0001094192,0.00001904058,0.000007318098,0.00001686504,0.00009009784],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.718895,"threshold_uncertainty_score":0.4173855,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03761913424189329,"score_gpt":0.4663444579850001,"score_spread":0.4287253237431068,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}